FDA Grants Tentative Approval for Aurobindo’s Antiretroviral Drug Abacavir
Indian drug manufacturer Aurobindo Pharma has received tentative approval from FDA to produce 300 mg tablets of abacavir sulfate, which is used in combination with other antiretroviral drugs to treat HIV-1 infection, the company announced on Tuesday, the Hindu Business Line reports. Abacavir is the generic version of GlaxoSmithKline's Ziagen. The product will be eligible for consideration under the President's Emergency Plan for AIDS Relief, according to a press release from the company (Hindu Business Line, 5/24).This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.